TY - JOUR
T1 - Current issues in the treatment of acne vulgaris
AU - Habeshian, Kaiane A.
AU - Cohen, Bernard A.
N1 - Publisher Copyright:
© 2020 by the American Academy of Pediatrics
PY - 2020/5
Y1 - 2020/5
N2 - Acne vulgaris is an extraordinarily common skin condition in adolescents. The mainstays of acne treatment have remained largely unchanged over recent years. In the context of increasing antibiotic resistance worldwide, there is a global movement away from antibiotic monotherapy toward their more restrictive use. Classically reserved for nodulocystic acne, isotretinoin has become the drug of choice by dermatologists for moderate to severe acne. Given the virtually ubiquitous nature of acne in teenagers, there remains an appreciable need for novel therapies. In this article, we will cover the currently used acne treatments, evaluate the issues and data supporting their use, explore the issues of compliance and the mental health implications of acne care, and recommend directions for the field of acne management in adolescents in the years ahead.
AB - Acne vulgaris is an extraordinarily common skin condition in adolescents. The mainstays of acne treatment have remained largely unchanged over recent years. In the context of increasing antibiotic resistance worldwide, there is a global movement away from antibiotic monotherapy toward their more restrictive use. Classically reserved for nodulocystic acne, isotretinoin has become the drug of choice by dermatologists for moderate to severe acne. Given the virtually ubiquitous nature of acne in teenagers, there remains an appreciable need for novel therapies. In this article, we will cover the currently used acne treatments, evaluate the issues and data supporting their use, explore the issues of compliance and the mental health implications of acne care, and recommend directions for the field of acne management in adolescents in the years ahead.
UR - http://www.scopus.com/inward/record.url?scp=85086801581&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086801581&partnerID=8YFLogxK
U2 - 10.1542/PEDS.2019-2056L
DO - 10.1542/PEDS.2019-2056L
M3 - Article
C2 - 32358215
AN - SCOPUS:85086801581
SN - 0031-4005
VL - 145
JO - Pediatrics
JF - Pediatrics
IS - 2
M1 - e20192056L
ER -